Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Kundel, Yulia ^a,c   Nasser, Nicola J ^a   Purim, Ofer ^a,c   Yerushalmi, Rinat ^a,c   Fenig, Eyal ^a,c   Pfeffer, Raphael M ^b,c   Stemmer, Salomon M ^a,c   Rizel, Shulamith ^a   Symon, Zvi ^b,c   Kaufman, Bella ^b,c   Sulkes, Aaron ^a,c   Brenner, Baruch ^a,c  

^a RABIN MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HAND FOOT SYNDROME; HUMAN; MUCOSA INFLAMMATION; NAUSEA; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; TREATMENT RESPONSE; WEAKNESS;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; CHEMORADIOTHERAPY; DEOXYCYTIDINE; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; PAIN; PAIN MANAGEMENT; PAIN MEASUREMENT; PALLIATIVE CARE; RADIOTHERAPY, CONFORMAL;

EID: 84880032585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068327     Document Type: Article

References (35)

1. Hoskin PJ, (1988) Scientific and clinical aspects of radiotherapy in the relief of bone pain. Cancer Surv 7: 69-86.
2. Tong D, Gillick L, Hendrickson FR, (1982) The palliation of symptomatic osseous metastases: the results of the Radiation Therapy Oncology Group. Cancer 50: 893-899.
3. Blitzer PH, (1985) Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 55: 1468-1472.
4. Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, et al. (1986) Prospective randomized trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 6: 247-255, 1986.
5. Ben-Josef E, Shamsa F, Youssef E, Porter AT, (1999) External beam radiotherapy for painful osseous metastases: pooled data dose response analysis. Int J Radiat Oncol Biol Phys 45: 715-719.
6. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F, (1982) Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X-rays. Int J Radiat Oncol Biol Phys 8: 1923-1933.
7. Nakajima V, Miyamoto Y, Tanabe M, Watanabe I, Terasima T, (1979) Enhancement of mammalian cell killing by 5-fluorouracil in combination with X-rays. Cancer Res 39: 3763-3767.
8. Lawrence TS, Davis MA, Maybaum I, (1994) Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects. Int J Radiat Oncol Biol Phys 29: 519-523.
9. Weinberg MJ, Rauth AM, (1987) 5-fluorouracil infusion and fractionated doses of radiation: Studies with a murine squamous cell carcinoma. Int J Radiat Oncol Biol Phys 13: 1691-1699.
10. Ryan DP, Compton CC, Mayer RJ, (2000) Carcinoma of the anal canal. N Engl J Med 342: 792-800.
11. Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, et al. (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24: 4620-4625.
12. Gastrointestinal Tumor Study Group (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59: 2006-2010.
13. Kalser MH, Ellenberg SS, (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120: 899-903.
14. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, et al. (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an Intergroup study. J Clin Oncol 15: 277-284.
15. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, et al. (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16: 1318-1324.
16. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, et al. (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340: 1137-1143.
17. Vaishampayan UN, Ben-Josef E, Philip PA, Vaitkevicius VK, Du W, et al. (2002) A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int J Radiat Oncol Biol Phys 53: 675-679.
18. Kim JS, Kim JS, Cho MJ, Song KS, Yoon WH, (2002) Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 54: 403-408.
19. Kim JC, Kim TW, Kim JH, Yu CS, Kim HC, et al. (2005) Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 63: 346-353.
20. De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, et al. (2006) Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol 17: 246-251.
21. Klautke G, Küchenmeister U, Foitzik T, Ludwig K, Prall F, et al. (2006) Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br J Cancer 94: 976-981.
22. Carlomagno C, Farella A, Bucci L, D'Armiento FP, Pesce G, et al. (2009) Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study. Ann Oncol 20: 906-912.
23. Ofner D, Devries AF, Schaberl-Moser R, Greil R, Rabl H, et al. (2011) Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT3NxM0, low rectal cancer: a phase II study. Strahlenther Onkol 187: 100-107.
24. Hong YS, Kim DY, Lim SB, Choi HS, Jeong SY, et al. (2011) Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study. Int J Radiat Oncol Biol Phys 79: 1171-1178.
25. Crane CH, Eng C, Feig BW, Das P, Skibber JM, et al. (2010) Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 76: 824-830.
26. Hofheinz R, Wenz FK, Post S, Matzdorff A, Laechelt S, et al. (2011) Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial. J Clin Oncol 29(suppl; abstr 3504).
27. The NCI Common Terminology Criteria for Adverse Events v3.0 Aug 2006.
28. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS, (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61: 277-284.
29. Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, et al. (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64: 275-280.
30. Wu JS, Wong R, Johnston M, Bezjak A, (2003) Whelan T; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55: 594-605.
31. Chow E, Harris K, Fan G, Tsao M, Sze WM, (2007) Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25: 1423-1436.
32. Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD, (2003) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of randomised trials. Clin Oncol 15: 345-352.
33. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, et al. (2005) Randomized trial of short versus long course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97: 798-804.
34. Van der Linden Y, Lokk JJ, Steenland E, (2004) Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys 59: 528-537.
35. Foro Arnalot P, Fontanals AV, Galcerán JC, Lynd F, Latiesas XS, et al. (2008) Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol 89: 150-155.